IP Law 360

APRIL 24, 2023

Drug companies Merck & Co. and Glenmark Pharmaceuticals on Monday settled with a group of retail pharmacies, narrowly avoiding a jury trial over allegations they conspired to keep a cheaper version of the cholesterol drug Zetia off the market more than two decades ago.

Marketing 40

Marketing Marketing 40

IP Law 360

FEBRUARY 23, 2023

Patent and Trademark Office to closely examine new patents for cancer drug Keytruda, warning that pharmaceutical company Merck & Co. A group of progressive congressional lawmakers, including Sen. Elizabeth Warren, D-Mass., have urged the U.S. is attempting to maintain its patent monopoly on the treatment.

Patent 40

Patent Trademark 40

43(B)log

FEBRUARY 4, 2022

TrustID, Inc. Next Caller, Inc., The parties compete to provide anti-spoofing and caller-authentication solutions for companies; TrustID has several relevant patents. Nor was the jury finding of willfulness sufficient to presume actual deception, at least in the Third Circuit (citing Johnson & Johnson-Merck Consumer Pharm.

Advertising 45

Advertising Advertising Patent Infringement Patent 45

43(B)log

NOVEMBER 19, 2021

Neurelis, Inc. Aquestive Therapeutics, Inc., In 2018, Aquestive did an IPO, and its Form S-1 represented that it was “further along” than other companies who were developing “other routes of administration” of diazepam for the treatment of ARS (that is, further along than Neurelis, which was allegedly untrue).

Designs 56

Designs Design Patent Prosecution Art 56

SpicyIP

DECEMBER 5, 2022

Livanova India Private Limited vs Godaddy.Com, Inc. & Levi Straus & Company vs. Sunil Yadav on 24 November, 2022 (Delhi District Court). Bennett, Coleman And Company Ltd. Levi Straus & Company vs Sh. Ajinomoto Co Inc vs Dattatrey Studios & Anr on 28 November, 2022 (Delhi High Court).

Trademark 105

Trademark Registering Trademarks Registration IP 105

Fish & Richardson Trademark & Copyright Thoughts

FEBRUARY 4, 2021

Samsung Bioepis/Merck). Samsung Bioepis/Merck). As of the March 23, 2020 transition, however, all “biological product” applications previously approved under the FD&C Act were “deemed” approved under the PHS Act, and companies can now seek biosimilars and interchangeables of these biological products. (Roche/Genentech).

Settlement 52

Settlement Litigation Marketing Marketing 52

SpicyIP

NOVEMBER 23, 2021

i] Merck & Co. Samsung Electronics Co. Gaurav Jerry MIPR 2014 (3) 101; Mattel Inc. & The Court affirmed that advertisements triggered by third-party trademarks will lead to confusion regarding the origin of the goods and services advertised. Is Google an intermediary? & Anr. Mediplan Health Consulting [425 F.

Trademark 137

Trademark Advertising Advertising Trademark Law 137